← Back to headlines
Eli Lilly Gains as Medicare Expansion of GLP-1 Weight Loss Drugs Eases Pricing Concerns
Eli Lilly and Company (LLY) stock has risen due to the expansion of Medicare coverage for GLP-1 weight loss drugs, which has alleviated pricing concerns.
18 Feb, 15:13 — 18 Feb, 15:13
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Strategy shows no fear — it keeps adding to a losing bitcoin position as prices drop
14m ago
Call for Affordable Banking Services for Small Associations
21m ago
Stock market extends losses as investors grapple with tariff uncertainty
23m ago
Nvidia, Salesforce, and Snowflake Earnings to Impact S&P 500
23m ago